That advances in gene transfer technology have led to the investigation of molecular strategies for replacement of normal insulin delivery function. Substantial progress has been made in engineering glucos-responsive β-cell lines and non-β-cell lines. In vivo transfer the insulin gene to animals can improved control of the diabetes. New therapeutic approaches to diabetes which are based on gene technology and implications for future are summarized.